Cite
HARVARD Citation
Isidori, A. et al. (2022). Real‐life efficacy and safety of idelalisib in 55 double‐refractory follicular lymphoma patients. British journal of haematology. pp. 339-343. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Isidori, A. et al. (2022). Real‐life efficacy and safety of idelalisib in 55 double‐refractory follicular lymphoma patients. British journal of haematology. pp. 339-343. [Online].